The FDA has appointed Dr Stephen Spielberg to the new post of Deputy Commissioner for Medical Products and Tobacco.
The appointment comes as part of a reorganisation of the Agency’s management structure, in a bid to ease agency-industry relations following Joshua Sharfstein’s exit of the FDA in January.
Peter Pitts, former FDA associate commissioner for external relations, commented that the reshuffle will bring “a stronger voice in agency policy development”.
Dr Spielberg’s post will oversee the centres for drugs, biologics, medical devices and tobacco products, as well as heading special medical programmes.
He currently works as Director of the Centre for Personalised Medicine and Therapeutic Innovation at Children’s Mercy Hospital in Kansas City and has previously worked at Merck and Johnson & Johnson.